HCP Plastene

Why is HCP Plastene Bulkpack Ltd falling/rising?

As of 01-Sep, HCP Plastene Bulkpack Ltd's stock price is at 276.90, reflecting a 4.97% increase. The stock has shown strong performance, gaining 16.69% in the past week and 51.52% in the last month, significantly outperforming the Sensex.

As of 01-Sep, HCP Plastene Bulkpack Ltd's stock price is rising, currently at 276.90, which reflects a change of 13.1 or 4.97% increase. This upward movement is supported by several factors. Over the past week, the stock has gained 16.69%, significantly outperforming the Sensex, which has declined by 0.92%. In the last month, the stock has surged by 51.52%, while the Sensex has fallen by 1.47%. Year-to-date, HCP Plastene has increased by 60.80%, contrasting with the Sensex's decline of 9.71%. <BR><BR>Additionally, the stock is close to its 52-week high, being only 2.71% away from Rs 284.45. Today's performance has also been strong, with the stock outperforming its sector by 4.8%. It has been on a consecutive gain streak for the last four days, accumulating a total return of 18.89% during this period. The stock opened with a gain of 4.98% today and reached an intraday high of Rs 276.95. <BR><BR>Furthermore, HCP Plastene is trading above all its moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a strong bullish trend. Investor participation has increased, with delivery volume rising by 126.45% compared to the 5-day average, suggesting heightened interest in the stock. Overall, these factors contribute to the stock's rising price.

Which are the latest news on HCP Plastene?

Who are in the management team of HCP Plastene?

The management team of HCP Plastene includes Anil Goyel (Chairman), Prakash Parekh (Managing Director), and several independent directors: Meenu Maheshwari, Ashutosh Sushil Kumar Maheshvari, Sandeep M Shah, Deepti Sharma, and Judhisthir Behera, along with Krushang Shah (Company Secretary & Compliance Officer).

The management team of HCP Plastene includes the following individuals:<BR><BR>1. Anil Goyel - Chairman (Non-Executive)<BR>2. Prakash Parekh - Managing Director<BR>3. Meenu Maheshwari - Independent Director<BR>4. Ashutosh Sushil Kumar Maheshvari - Independent Director<BR>5. Sandeep M Shah - Independent Director<BR>6. Krushang Shah - Company Secretary & Compliance Officer<BR>7. Deepti Sharma - Independent Director<BR>8. Judhisthir Behera - Independent Director<BR><BR>If you need more information about any specific member or their roles, feel free to ask!

What does HCP Plastene do?

HCP Plastene Bulkpack Ltd is a micro-cap company in the plastics packaging industry, reporting net sales of 174 Cr and a net profit of 14 Cr for June 2026. The company, formerly known as Gopala Polyplast Limited, has a market cap of INR 282 Cr and key metrics including a P/E ratio of 9.00 and a dividend yield of 0.40%.

Overview:<BR>HCP Plastene Bulkpack Ltd operates in the plastics packaging industry and is categorized as a micro-cap company.<BR><BR>History:<BR>The company was incorporated in 1984 and was formerly known as Gopala Polyplast Limited. It changed its name to HCP Plastene Bulkpack Limited on September 22, 2021. The latest quarterly results reported net sales and profit for June 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 174 Cr (Quarterly Results - Jun 2026)<BR>- Net Profit: 14 Cr (Quarterly Results - Jun 2026)<BR>- Market Cap: INR 282 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 9.00<BR>- Industry P/E: 18<BR>- Dividend Yield: 0.40%<BR>- Debt-Equity: 2.81<BR>- Return on Equity: 28.47%<BR>- Price to Book: 3.28<BR><BR>Contact Details:<BR>Address: H B Jirawala House, Navbharat Soc Ushmanpura Ahmedabad Gujarat : 380013<BR>Email: hdpeaccounts@gopalapolyplast.com<BR>Website: http://www.gopalapolyplast.com

Who are the peers of the HCP Plastene?

HCP Plastene's peers include Nahar Poly, B&B Triplewall, RDB Rasayans, Cropster Agro, GLEN Industries, Mitsu Chem Plast, Worth Peripheral, Shree TirupatiBa, and Aeroflex Neu. Mitsu Chem Plast has the highest 1-year return at 75.01%, while HCP Plastene's return is 53.86%, outperforming several peers with negative returns.

Peers: The peers of HCP Plastene are Nahar Poly, B&B Triplewall, RDB Rasayans, Cropster Agro, GLEN Industries, Mitsu Chem Plast, Worth Peripheral, Shree TirupatiBa, and Aeroflex Neu.<BR><BR>Quality Snapshot: Excellent management risk is observed at RDB Rasayans and Cropster Agro, while Average management risk is found at Nahar Poly, GLEN Industries, Mitsu Chem Plast, and Worth Peripheral, and the rest. Below Average management risk is present at B&B Triplewall, Shree TirupatiBa, Aeroflex Neu. Growth is Excellent at Cropster Agro, Good at GLEN Industries, and Below Average at Nahar Poly, RDB Rasayans, HCP Plastene, Mitsu Chem Plast, Worth Peripheral, and the rest. Below Average growth is also seen at B&B Triplewall, Shree TirupatiBa, Aeroflex Neu. Capital Structure is Excellent at RDB Rasayans and Worth Peripheral, Good at Nahar Poly, and Below Average at B&B Triplewall, GLEN Industries, HCP Plastene, Mitsu Chem Plast, Shree TirupatiBa, Aeroflex Neu.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Mitsu Chem Plast at 75.01%, while the peer with the lowest is Cropster Agro at -81.71%. HCP Plastene's 1-year return of 53.86% is higher than that of RDB Rasayans, Worth Peripheral, Shree TirupatiBa, and Aeroflex Neu, which all have negative six-month returns.

How big is HCP Plastene?

As of 31st August, HCP Plastene Bulkpack Ltd has a market capitalization of 282.00 Cr, with net sales of 635.95 Cr and a net profit of 32.99 Cr reported in the latest four quarters.

As of 31st August, HCP Plastene Bulkpack Ltd has a market capitalization of 282.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, HCP Plastene reported net sales of 635.95 Cr and a net profit of 32.99 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with shareholder's funds amounting to 59.57 Cr and total assets valued at 260.90 Cr.

Should I buy, sell or hold HCP Plastene Bulkpack Ltd?

Are HCP Plastene Bulkpack Ltd latest results good or bad?

HCP Plastene Bulkpack Ltd's latest results show strong profit and sales growth, with a net profit of ₹8.21 crores for Q4 FY26, up 16.95% QoQ and 62.90% YoY. However, the operating margin fell to 11.61%, raising concerns about profitability despite the positive revenue trends.

HCP Plastene Bulkpack Ltd's latest results present a mixed picture. On the positive side, the company reported a consolidated net profit of ₹8.21 crores for Q4 FY26, which is a significant increase of 16.95% quarter-on-quarter (QoQ) and a remarkable 62.90% year-on-year (YoY) growth. Additionally, net sales rose by 17.75% QoQ to ₹142.79 crores, indicating a recovery from a previous decline.<BR><BR>However, there are concerns regarding the operating margin, which fell sharply to 11.61%, down 414 basis points from the previous quarter. This decline suggests potential challenges in maintaining profitability despite the revenue growth, possibly due to rising costs or pricing pressures.<BR><BR>Overall, while the profit and sales growth are encouraging, the margin compression raises caution among investors, reflecting a nuanced performance that may warrant further observation in the coming quarters.

When is the next results date for HCP Plastene Bulkpack Ltd?

The next results date for HCP Plastene Bulkpack Ltd is 12 August 2026.

The next results date for HCP Plastene Bulkpack Ltd is scheduled for 12 August 2026.

How has been the historical performance of HCP Plastene?

HCP Plastene's historical performance has shown significant fluctuations, with net sales peaking at 11,219.74 Cr in March 2022 before declining to 463.48 Cr by March 2025, while profitability metrics have improved, turning positive in March 2025 after previous losses. Despite ongoing challenges in cash flow from operations, the company has demonstrated signs of recovery in operating profit and net profit.

Answer:<BR>The historical performance of HCP Plastene shows significant fluctuations in key financial metrics over the years.<BR><BR>Breakdown:<BR>HCP Plastene's net sales have varied dramatically, peaking at 11,219.74 Cr in March 2022 before declining to 463.48 Cr in March 2025. The total operating income followed a similar trend, reaching its highest at 11,219.74 Cr in March 2022 and dropping to 463.48 Cr by March 2025. Raw material costs also surged, from 13.67 Cr in March 2021 to 350.34 Cr in March 2025. Operating profit, which was negative in March 2021, improved to 39.87 Cr by March 2025, indicating a recovery despite the decline in sales. Profit before tax turned positive at 17.96 Cr in March 2025, up from a loss of 315.92 Cr in March 2022. The profit after tax showed a similar recovery, reaching 13.31 Cr in March 2025 after being negative in previous years. The consolidated net profit also turned positive at 9.63 Cr in March 2025, compared to losses in the preceding years. On the balance sheet, total liabilities increased from 48.70 Cr in March 2021 to 206.70 Cr in March 2024, while total assets rose from 48.70 Cr to 206.70 Cr in the same period. Cash flow from operating activities remained negative, indicating ongoing challenges in generating cash from core operations. Overall, HCP Plastene has shown signs of recovery in profitability metrics despite significant fluctuations in sales and costs.

Has HCP Plastene declared dividend?

HCP Plastene has declared a 10% dividend, with an ex-date of November 14, 2025. Despite the dividend declaration, the dividend yield is 0%, and total returns have varied significantly across different time periods.

HCP Plastene has declared a 10% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 10%<BR>- Ex-date: 14 Nov 25<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the last 3 months, HCP Plastene experienced a price return of 6.48%, a dividend return of 0.56%, leading to a total return of 7.04%.<BR><BR>Over the 6-month period, the company saw an impressive price return of 81.68%, with a dividend return of 0.89%, resulting in a total return of 82.57%.<BR><BR>For the 1-year period, the price return was 16.13%, the dividend return was 0.59%, culminating in a total return of 16.72%.<BR><BR>In the 2-year period, HCP Plastene had a price return of -8.34%, a dividend return of 0.48%, which resulted in a total return of -7.86%.<BR><BR>Over the 3 years, the company faced a price return of -45.96%, with a dividend return of 0.29%, leading to a total return of -45.67%.<BR><BR>In the 4-year period, HCP Plastene recorded a price return of -75.43%, a dividend return of 0.15%, resulting in a total return of -75.28%.<BR><BR>Finally, over the 5-year period, the company achieved a remarkable price return of 3031.75%, with no dividend return, leading to a total return of 3031.75%.<BR><BR>Overall, HCP Plastene has declared a dividend, but the dividend yield remains at 0%. The total returns show significant variability, with strong performance over the 5-year period contrasted by negative returns in shorter time frames.

How has been the historical performance of HCP Plastene?

HCP Plastene's historical performance shows a recovery in net sales and profitability, with net sales rising to 463.44 Cr in Mar'25 from 294.56 Cr in Mar'24, and profit after tax increasing to 13.36 Cr. However, the company faces challenges with rising liabilities and negative cash flow from operating activities.

Answer:<BR>The historical performance of HCP Plastene shows significant fluctuations in key financial metrics over the years.<BR><BR>Breakdown:<BR>HCP Plastene's net sales experienced a notable increase from Mar'24 at 294.56 Cr to Mar'25 at 463.44 Cr, following a dip in Mar'23 at 351.56 Cr and a dramatic decline from Mar'22's 11,219.74 Cr. Total operating income mirrored this trend, rising to 463.44 Cr in Mar'25 from 294.56 Cr in Mar'24. The raw material cost also increased significantly, reaching 350.29 Cr in Mar'25 from 212.20 Cr in Mar'24, while total expenditure rose to 428.20 Cr in Mar'25. Operating profit (PBDIT) improved to 39.92 Cr in Mar'25, up from 19.23 Cr in Mar'24, indicating a recovery from the previous years' losses. Profit before tax turned positive at 18.01 Cr in Mar'25, compared to a mere 0.20 Cr in Mar'24, and profit after tax rose to 13.36 Cr from 0.31 Cr. The consolidated net profit for Mar'25 was 9.63 Cr, a recovery from losses in the previous years. Earnings per share (EPS) also improved to 9.03 in Mar'25 from -1.12 in Mar'24. However, the company faced challenges with total liabilities increasing to 206.70 Cr in Mar'24 from 175.25 Cr in Mar'23, and total debt rising to 157.90 Cr. Cash flow from operating activities remained negative at -18.00 Cr in Mar'24, though cash flow from financing activities was positive at 23.00 Cr. Overall, HCP Plastene's financial performance indicates a recovery trend in sales and profitability, despite ongoing challenges with liabilities and cash flow.

Is HCP Plastene overvalued or undervalued?

As of October 28, 2025, HCP Plastene is considered undervalued with an attractive valuation grade, featuring a PE ratio of 14.48, an EV to EBITDA of 9.63, and a PEG ratio of 0.02, significantly outperforming peers like Garware Hi Tech and TCPL Packaging, and demonstrating a remarkable 3525.28% return over five years compared to the Sensex's 111.98%.

As of 28 October 2025, HCP Plastene's valuation grade has moved from fair to attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued, especially when compared to its peers. Key ratios include a PE ratio of 14.48, an EV to EBITDA of 9.63, and a PEG ratio of 0.02, which suggests significant growth potential relative to its price.<BR><BR>In the peer comparison, HCP Plastene's PE ratio is notably lower than Garware Hi Tech's 24.96 and TCPL Packaging's 22.52, both of which are classified as expensive. Additionally, AGI Greenpac, which is very attractive, has a PE ratio of 15.19, further reinforcing HCP Plastene's undervaluation. Despite a recent decline in stock price, the long-term performance shows a remarkable 3525.28% return over five years, significantly outpacing the Sensex's 111.98% return in the same period, highlighting its potential for recovery and growth.

What is the technical trend for HCP Plastene?

As of June 2, 2025, HCP Plastene's technical trend is mildly bearish, indicated by daily moving averages and monthly Bollinger Bands, despite some conflicting signals from weekly MACD and KST.

As of 2 June 2025, the technical trend for HCP Plastene has changed from sideways to mildly bearish. The daily moving averages indicate a mildly bearish stance, while the weekly MACD and KST are mildly bullish, suggesting some conflicting signals. The Bollinger Bands show a bearish trend on the monthly timeframe, which adds to the bearish outlook. Overall, the current technical stance is mildly bearish, driven primarily by the daily moving averages and the bearish signal from the monthly Bollinger Bands.

Who are the top shareholders of the HCP Plastene?

The top shareholders of HCP Plastene include Aman Prakash Parekh with 16.86%, Bank of Baroda as the largest public shareholder at 4.8%, and individual investors holding a total of 12.81%. Additionally, foreign institutional investors hold a combined 0.07%, while mutual funds have a negligible stake.

The top shareholders of HCP Plastene include the promoters, with Aman Prakash Parekh holding the highest individual stake at 16.86%. Additionally, Bank of Baroda is the largest public shareholder, owning 4.8%. The company also has some institutional investment, with three foreign institutional investors (FIIs) holding a combined 0.07%, and mutual funds are represented by one scheme, which holds 0.0%. Individual investors collectively hold 12.81% of the shares.